(Q37939626)

25 August 2017

1 reference

title

Cancer-promoting tumor-associated macrophages: new vistas and open questions (English)

1 reference

25 August 2017

0 references

1

1 reference

25 August 2017

3

1 reference

25 August 2017

5

Subhra K Biswas

1 reference

25 August 2017

Giovanni Germano

2

1 reference

PubMed ID

21952810

25 August 2017

Marco Locatelli

series ordinal

4

1 reference

PubMed ID

21952810

25 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

European Journal of Immunology

25 August 2017

1 reference

25 August 2017

41

1 reference

25 August 2017

9

1 reference

25 August 2017

2522-2525

1 reference

Cancer-related inflammation

25 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Cancer and inflammation: implications for pharmacology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

The chemokine system in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Chemokines and chemokine receptors: new insights into cancer-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Colony-stimulating factors in inflammation and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Modulation of the antitumor immune response by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Macrophage polarization to a unique phenotype driven by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Convergent pathways of macrophage polarization: The role of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

Significance of M2-polarized tumor-associated macrophage in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

Regulation of the macrophage content of neoplasms by chemoattractants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

Human glioma tumors express high levels of the chemokine receptor CX3CR1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

FACS analysis of tumor-associated macrophage replication: differences between metastatic and nonmetastatic murine mammary tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141894

7 January 2021

Identifiers

DOI

10.1002/EJI.201141894

1 reference

25 August 2017

1 reference

PubMed ID

21952810